South Dakota Medical Cannabis Recall Due to Testing and Labeling Concerns

The South Dakota Medical Cannabis Program (SDMCP) has requested a voluntary recall for products from 605 Cannabis, also known as Badlands, due to allegations of testing failures, mislabeling, contamination, lack of inventory tracking, and failure to have licenses for edible products. The recall is a precautionary measure to protect patients and ensure the safety and quality of medical cannabis products.

Badlands is cooperating with the recall, and dispensaries have been instructed to contact patients who may have purchased the affected products. Patients who have the product in their possession are advised to destroy it or return it to the dispensary where it was purchased.

The recall raises concerns about the safety and efficacy of medical cannabis products, and highlights the importance of rigorous testing and labeling standards in the industry. The SDMCP is committed to protecting the health and well-being of patients who use medical cannabis, and it will continue to conduct routine testing and regulation to ensure the quality and safety of products in the state.

Anyone with adverse health effects from consuming the recalled medical cannabis is advised to seek medical attention immediately. The recall serves as a reminder of the importance of continued vigilance in the regulation of medical cannabis products to ensure that patients have access to safe and effective products. (Source)

0 0 votes
Article Rating
Notify of
Inline Feedbacks
View all comments